世界のマックルウェルズ症候群市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Muckle-Wells Syndrome Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3940
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、マックルウェルズ症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（周期的症候群、CIAS1遺伝子ポリアミド変異、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・マックルウェルズ症候群の市場動向
・企業の競争状況、市場シェア
・マックルウェルズ症候群の種類別市場規模（周期的症候群、CIAS1遺伝子ポリアミド変異、その他）
・マックルウェルズ症候群の用途別市場規模（病院、クリニック、その他）
・マックルウェルズ症候群の北米市場規模2016-2027（アメリカ、カナダ）
・マックルウェルズ症候群のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・マックルウェルズ症候群のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・マックルウェルズ症候群の中南米市場規模2016-2027（メキシコ、ブラジル）
・マックルウェルズ症候群の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novartis AG、Istituto Giannina Gaslini、Regeneron Pharmaceuticals, Inc.、Charite-Universitatsmedizin Berlin、Fresenius Medical Care、Huaren Pharmaceutical、NephroPlus、Nipro、Swedish Orphan Biovitrum AB、Kiniksa Pharmaceuticals）
・結論

Muckle-Wells syndrome is a genetic autosomal disease which leads to disorders such as urticaria, sensorineural deafness, and also leads to amyloidosis.

Market Analysis and Insights: Global Muckle-Wells Syndrome Market
The global Muckle-Wells Syndrome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Muckle-Wells Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Muckle-Wells Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Muckle-Wells Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Muckle-Wells Syndrome market.

Global Muckle-Wells Syndrome Scope and Market Size
Muckle-Wells Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Muckle-Wells Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast By Family of Cryopyrin and by End Users in terms of revenue and forecast for the period 2016-2027.

Segment By Family of Cryopyrin
Associated Periodic Syndromes
Mutation Of CIAS1 Gene Polyamide
Others

Segment by End Users
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis AG
Istituto Giannina Gaslini
Regeneron Pharmaceuticals, Inc.
Charite-Universitatsmedizin Berlin
Fresenius Medical Care
Huaren Pharmaceutical
NephroPlus
Nipro
Swedish Orphan Biovitrum AB

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Muckle-Wells Syndrome Market Size Growth Rate By Family of Cryopyrin: 2016 VS 2021 VS 2027
1.2.2 Associated Periodic Syndromes
1.2.3 Mutation Of CIAS1 Gene Polyamide
1.2.4 Others
1.3 Market by Application
1.3.1 Global Muckle-Wells Syndrome Market Share by End Users: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Muckle-Wells Syndrome Market Perspective (2016-2027)
2.2 Muckle-Wells Syndrome Growth Trends by Regions
2.2.1 Muckle-Wells Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Muckle-Wells Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Muckle-Wells Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Muckle-Wells Syndrome Industry Dynamic
2.3.1 Muckle-Wells Syndrome Market Trends
2.3.2 Muckle-Wells Syndrome Market Drivers
2.3.3 Muckle-Wells Syndrome Market Challenges
2.3.4 Muckle-Wells Syndrome Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Muckle-Wells Syndrome Players by Revenue
3.1.1 Global Top Muckle-Wells Syndrome Players by Revenue (2016-2021)
3.1.2 Global Muckle-Wells Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Muckle-Wells Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Muckle-Wells Syndrome Revenue
3.4 Global Muckle-Wells Syndrome Market Concentration Ratio
3.4.1 Global Muckle-Wells Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Muckle-Wells Syndrome Revenue in 2020
3.5 Muckle-Wells Syndrome Key Players Head office and Area Served
3.6 Key Players Muckle-Wells Syndrome Product Solution and Service
3.7 Date of Enter into Muckle-Wells Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Muckle-Wells Syndrome Breakdown Data By Family of Cryopyrin
4.1 Global Muckle-Wells Syndrome Historic Market Size By Family of Cryopyrin (2016-2021)
4.2 Global Muckle-Wells Syndrome Forecasted Market Size By Family of Cryopyrin (2022-2027)

5 Muckle-Wells Syndrome Breakdown Data by End Users
5.1 Global Muckle-Wells Syndrome Historic Market Size by End Users (2016-2021)
5.2 Global Muckle-Wells Syndrome Forecasted Market Size by End Users (2022-2027)

6 North America
6.1 North America Muckle-Wells Syndrome Market Size (2016-2027)
6.2 North America Muckle-Wells Syndrome Market Size By Family of Cryopyrin
6.2.1 North America Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2021)
6.2.2 North America Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2022-2027)
6.2.3 North America Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2027)
6.3 North America Muckle-Wells Syndrome Market Size by End Users
6.3.1 North America Muckle-Wells Syndrome Market Size by End Users (2016-2021)
6.3.2 North America Muckle-Wells Syndrome Market Size by End Users (2022-2027)
6.3.3 North America Muckle-Wells Syndrome Market Size by End Users (2016-2027)
6.4 North America Muckle-Wells Syndrome Market Size by Country
6.4.1 North America Muckle-Wells Syndrome Market Size by Country (2016-2021)
6.4.2 North America Muckle-Wells Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Muckle-Wells Syndrome Market Size (2016-2027)
7.2 Europe Muckle-Wells Syndrome Market Size By Family of Cryopyrin
7.2.1 Europe Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2021)
7.2.2 Europe Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2022-2027)
7.2.3 Europe Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2027)
7.3 Europe Muckle-Wells Syndrome Market Size by End Users
7.3.1 Europe Muckle-Wells Syndrome Market Size by End Users (2016-2021)
7.3.2 Europe Muckle-Wells Syndrome Market Size by End Users (2022-2027)
7.3.3 Europe Muckle-Wells Syndrome Market Size by End Users (2016-2027)
7.4 Europe Muckle-Wells Syndrome Market Size by Country
7.4.1 Europe Muckle-Wells Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Muckle-Wells Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Muckle-Wells Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Muckle-Wells Syndrome Market Size By Family of Cryopyrin
8.2.1 Asia-Pacific Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2021)
8.2.2 Asia-Pacific Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2022-2027)
8.2.3 Asia-Pacific Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2027)
8.3 Asia-Pacific Muckle-Wells Syndrome Market Size by End Users
8.3.1 Asia-Pacific Muckle-Wells Syndrome Market Size by End Users (2016-2021)
8.3.2 Asia-Pacific Muckle-Wells Syndrome Market Size by End Users (2022-2027)
8.3.3 Asia-Pacific Muckle-Wells Syndrome Market Size by End Users (2016-2027)
8.4 Asia-Pacific Muckle-Wells Syndrome Market Size by Region
8.4.1 Asia-Pacific Muckle-Wells Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Muckle-Wells Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Muckle-Wells Syndrome Market Size (2016-2027)
9.2 Latin America Muckle-Wells Syndrome Market Size By Family of Cryopyrin
9.2.1 Latin America Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2021)
9.2.2 Latin America Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2022-2027)
9.2.3 Latin America Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2027)
9.3 Latin America Muckle-Wells Syndrome Market Size by End Users
9.3.1 Latin America Muckle-Wells Syndrome Market Size by End Users (2016-2021)
9.3.2 Latin America Muckle-Wells Syndrome Market Size by End Users (2022-2027)
9.3.3 Latin America Muckle-Wells Syndrome Market Size by End Users (2016-2027)
9.4 Latin America Muckle-Wells Syndrome Market Size by Country
9.4.1 Latin America Muckle-Wells Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Muckle-Wells Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Muckle-Wells Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Muckle-Wells Syndrome Market Size By Family of Cryopyrin
10.2.1 Middle East & Africa Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2021)
10.2.2 Middle East & Africa Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2022-2027)
10.2.3 Middle East & Africa Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2027)
10.3 Middle East & Africa Muckle-Wells Syndrome Market Size by End Users
10.3.1 Middle East & Africa Muckle-Wells Syndrome Market Size by End Users (2016-2021)
10.3.2 Middle East & Africa Muckle-Wells Syndrome Market Size by End Users (2022-2027)
10.3.3 Middle East & Africa Muckle-Wells Syndrome Market Size by End Users (2016-2027)
10.4 Middle East & Africa Muckle-Wells Syndrome Market Size by Country
10.4.1 Middle East & Africa Muckle-Wells Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Muckle-Wells Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Muckle-Wells Syndrome Introduction
11.1.4 Novartis AG Revenue in Muckle-Wells Syndrome Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Istituto Giannina Gaslini
11.2.1 Istituto Giannina Gaslini Company Details
11.2.2 Istituto Giannina Gaslini Business Overview
11.2.3 Istituto Giannina Gaslini Muckle-Wells Syndrome Introduction
11.2.4 Istituto Giannina Gaslini Revenue in Muckle-Wells Syndrome Business (2016-2021)
11.2.5 Istituto Giannina Gaslini Recent Development
11.3 Regeneron Pharmaceuticals, Inc.
11.3.1 Regeneron Pharmaceuticals, Inc. Company Details
11.3.2 Regeneron Pharmaceuticals, Inc. Business Overview
11.3.3 Regeneron Pharmaceuticals, Inc. Muckle-Wells Syndrome Introduction
11.3.4 Regeneron Pharmaceuticals, Inc. Revenue in Muckle-Wells Syndrome Business (2016-2021)
11.3.5 Regeneron Pharmaceuticals, Inc. Recent Development
11.4 Charite-Universitatsmedizin Berlin
11.4.1 Charite-Universitatsmedizin Berlin Company Details
11.4.2 Charite-Universitatsmedizin Berlin Business Overview
11.4.3 Charite-Universitatsmedizin Berlin Muckle-Wells Syndrome Introduction
11.4.4 Charite-Universitatsmedizin Berlin Revenue in Muckle-Wells Syndrome Business (2016-2021)
11.4.5 Charite-Universitatsmedizin Berlin Recent Development
11.5 Fresenius Medical Care
11.5.1 Fresenius Medical Care Company Details
11.5.2 Fresenius Medical Care Business Overview
11.5.3 Fresenius Medical Care Muckle-Wells Syndrome Introduction
11.5.4 Fresenius Medical Care Revenue in Muckle-Wells Syndrome Business (2016-2021)
11.5.5 Fresenius Medical Care Recent Development
11.6 Huaren Pharmaceutical
11.6.1 Huaren Pharmaceutical Company Details
11.6.2 Huaren Pharmaceutical Business Overview
11.6.3 Huaren Pharmaceutical Muckle-Wells Syndrome Introduction
11.6.4 Huaren Pharmaceutical Revenue in Muckle-Wells Syndrome Business (2016-2021)
11.6.5 Huaren Pharmaceutical Recent Development
11.7 NephroPlus
11.7.1 NephroPlus Company Details
11.7.2 NephroPlus Business Overview
11.7.3 NephroPlus Muckle-Wells Syndrome Introduction
11.7.4 NephroPlus Revenue in Muckle-Wells Syndrome Business (2016-2021)
11.7.5 NephroPlus Recent Development
11.8 Nipro
11.8.1 Nipro Company Details
11.8.2 Nipro Business Overview
11.8.3 Nipro Muckle-Wells Syndrome Introduction
11.8.4 Nipro Revenue in Muckle-Wells Syndrome Business (2016-2021)
11.8.5 Nipro Recent Development
11.9 Swedish Orphan Biovitrum AB
11.9.1 Swedish Orphan Biovitrum AB Company Details
11.9.2 Swedish Orphan Biovitrum AB Business Overview
11.9.3 Swedish Orphan Biovitrum AB Muckle-Wells Syndrome Introduction
11.9.4 Swedish Orphan Biovitrum AB Revenue in Muckle-Wells Syndrome Business (2016-2021)
11.9.5 Swedish Orphan Biovitrum AB Recent Development
11.10 Kiniksa Pharmaceuticals
11.10.1 Kiniksa Pharmaceuticals Company Details
11.10.2 Kiniksa Pharmaceuticals Business Overview
11.10.3 Kiniksa Pharmaceuticals Muckle-Wells Syndrome Introduction
11.10.4 Kiniksa Pharmaceuticals Revenue in Muckle-Wells Syndrome Business (2016-2021)
11.10.5 Kiniksa Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Muckle-Wells Syndrome Market Size Growth Rate By Family of Cryopyrin (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Associated Periodic Syndromes
Table 3. Key Players of Mutation Of CIAS1 Gene Polyamide
Table 4. Key Players of Others
Table 5. Global Muckle-Wells Syndrome Market Size Growth by End Users (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Muckle-Wells Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Muckle-Wells Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Muckle-Wells Syndrome Market Share by Regions (2016-2021)
Table 9. Global Muckle-Wells Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Muckle-Wells Syndrome Market Share by Regions (2022-2027)
Table 11. Muckle-Wells Syndrome Market Trends
Table 12. Muckle-Wells Syndrome Market Drivers
Table 13. Muckle-Wells Syndrome Market Challenges
Table 14. Muckle-Wells Syndrome Market Restraints
Table 15. Global Muckle-Wells Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Muckle-Wells Syndrome Market Share by Players (2016-2021)
Table 17. Global Top Muckle-Wells Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Muckle-Wells Syndrome as of 2020)
Table 18. Ranking of Global Top Muckle-Wells Syndrome Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Muckle-Wells Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Muckle-Wells Syndrome Product Solution and Service
Table 22. Date of Enter into Muckle-Wells Syndrome Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2021) (US$ Million)
Table 25. Global Muckle-Wells Syndrome Revenue Market Share By Family of Cryopyrin (2016-2021)
Table 26. Global Muckle-Wells Syndrome Forecasted Market Size By Family of Cryopyrin (2022-2027) (US$ Million)
Table 27. Global Muckle-Wells Syndrome Revenue Market Share By Family of Cryopyrin (2022-2027) & (US$ Million)
Table 28. Global Muckle-Wells Syndrome Market Size Share by End Users (2016-2021) & (US$ Million)
Table 29. Global Muckle-Wells Syndrome Revenue Market Share by End Users (2016-2021)
Table 30. Global Muckle-Wells Syndrome Forecasted Market Size by End Users (2022-2027) (US$ Million)
Table 31. Global Muckle-Wells Syndrome Revenue Market Share by End Users (2022-2027) & (US$ Million)
Table 32. North America Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2021) (US$ Million)
Table 33. North America Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2022-2027) & (US$ Million)
Table 34. North America Muckle-Wells Syndrome Market Size by End Users (2016-2021) (US$ Million)
Table 35. North America Muckle-Wells Syndrome Market Size by End Users (2022-2027) & (US$ Million)
Table 36. North America Muckle-Wells Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Muckle-Wells Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2021) (US$ Million)
Table 39. Europe Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2022-2027) & (US$ Million)
Table 40. Europe Muckle-Wells Syndrome Market Size by End Users (2016-2021) (US$ Million)
Table 41. Europe Muckle-Wells Syndrome Market Size by End Users (2022-2027) & (US$ Million)
Table 42. Europe Muckle-Wells Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Muckle-Wells Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2021) (US$ Million)
Table 45. Asia-Pacific Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Muckle-Wells Syndrome Market Size by End Users (2016-2021) (US$ Million)
Table 47. Asia-Pacific Muckle-Wells Syndrome Market Size by End Users (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Muckle-Wells Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Muckle-Wells Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2021) (US$ Million)
Table 51. Latin America Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2022-2027) & (US$ Million)
Table 52. Latin America Muckle-Wells Syndrome Market Size by End Users (2016-2021) (US$ Million)
Table 53. Latin America Muckle-Wells Syndrome Market Size by End Users (2022-2027) & (US$ Million)
Table 54. Latin America Muckle-Wells Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Muckle-Wells Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2016-2021) (US$ Million)
Table 57. Middle East & Africa Muckle-Wells Syndrome Market Size By Family of Cryopyrin (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Muckle-Wells Syndrome Market Size by End Users (2016-2021) (US$ Million)
Table 59. Middle East & Africa Muckle-Wells Syndrome Market Size by End Users (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Muckle-Wells Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Muckle-Wells Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 62. Novartis AG Company Details
Table 63. Novartis AG Business Overview
Table 64. Novartis AG Muckle-Wells Syndrome Product
Table 65. Novartis AG Revenue in Muckle-Wells Syndrome Business (2016-2021) & (US$ Million)
Table 66. Novartis AG Recent Development
Table 67. Istituto Giannina Gaslini Company Details
Table 68. Istituto Giannina Gaslini Business Overview
Table 69. Istituto Giannina Gaslini Muckle-Wells Syndrome Product
Table 70. Istituto Giannina Gaslini Revenue in Muckle-Wells Syndrome Business (2016-2021) & (US$ Million)
Table 71. Istituto Giannina Gaslini Recent Development
Table 72. Regeneron Pharmaceuticals, Inc. Company Details
Table 73. Regeneron Pharmaceuticals, Inc. Business Overview
Table 74. Regeneron Pharmaceuticals, Inc. Muckle-Wells Syndrome Product
Table 75. Regeneron Pharmaceuticals, Inc. Revenue in Muckle-Wells Syndrome Business (2016-2021) & (US$ Million)
Table 76. Regeneron Pharmaceuticals, Inc. Recent Development
Table 77. Charite-Universitatsmedizin Berlin Company Details
Table 78. Charite-Universitatsmedizin Berlin Business Overview
Table 79. Charite-Universitatsmedizin Berlin Muckle-Wells Syndrome Product
Table 80. Charite-Universitatsmedizin Berlin Revenue in Muckle-Wells Syndrome Business (2016-2021) & (US$ Million)
Table 81. Charite-Universitatsmedizin Berlin Recent Development
Table 82. Fresenius Medical Care Company Details
Table 83. Fresenius Medical Care Business Overview
Table 84. Fresenius Medical Care Muckle-Wells Syndrome Product
Table 85. Fresenius Medical Care Revenue in Muckle-Wells Syndrome Business (2016-2021) & (US$ Million)
Table 86. Fresenius Medical Care Recent Development
Table 87. Huaren Pharmaceutical Company Details
Table 88. Huaren Pharmaceutical Business Overview
Table 89. Huaren Pharmaceutical Muckle-Wells Syndrome Product
Table 90. Huaren Pharmaceutical Revenue in Muckle-Wells Syndrome Business (2016-2021) & (US$ Million)
Table 91. Huaren Pharmaceutical Recent Development
Table 92. NephroPlus Company Details
Table 93. NephroPlus Business Overview
Table 94. NephroPlus Muckle-Wells Syndrome Product
Table 95. NephroPlus Revenue in Muckle-Wells Syndrome Business (2016-2021) & (US$ Million)
Table 96. NephroPlus Recent Development
Table 97. Nipro Company Details
Table 98. Nipro Business Overview
Table 99. Nipro Revenue in Muckle-Wells Syndrome Business (2016-2021) & (US$ Million)
Table 100. Nipro Recent Development
Table 101. Swedish Orphan Biovitrum AB Company Details
Table 102. Swedish Orphan Biovitrum AB Business Overview
Table 103. Swedish Orphan Biovitrum AB Muckle-Wells Syndrome Product
Table 104. Swedish Orphan Biovitrum AB Revenue in Muckle-Wells Syndrome Business (2016-2021) & (US$ Million)
Table 105. Swedish Orphan Biovitrum AB Recent Development
Table 106. Kiniksa Pharmaceuticals Company Details
Table 107. Kiniksa Pharmaceuticals Business Overview
Table 108. Kiniksa Pharmaceuticals Muckle-Wells Syndrome Product
Table 109. Kiniksa Pharmaceuticals Revenue in Muckle-Wells Syndrome Business (2016-2021) & (US$ Million)
Table 110. Kiniksa Pharmaceuticals Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Muckle-Wells Syndrome Market Share By Family of Cryopyrin: 2020 VS 2027
Figure 2. Associated Periodic Syndromes Features
Figure 3. Mutation Of CIAS1 Gene Polyamide Features
Figure 4. Others Features
Figure 5. Global Muckle-Wells Syndrome Market Share by End Users: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Muckle-Wells Syndrome Report Years Considered
Figure 10. Global Muckle-Wells Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Muckle-Wells Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Muckle-Wells Syndrome Market Share by Regions: 2020 VS 2027
Figure 13. Global Muckle-Wells Syndrome Market Share by Regions (2022-2027)
Figure 14. Global Muckle-Wells Syndrome Market Share by Players in 2020
Figure 15. Global Top Muckle-Wells Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Muckle-Wells Syndrome as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Muckle-Wells Syndrome Revenue in 2020
Figure 17. Global Muckle-Wells Syndrome Revenue Market Share By Family of Cryopyrin (2016-2021)
Figure 18. Global Muckle-Wells Syndrome Revenue Market Share By Family of Cryopyrin (2022-2027)
Figure 19. North America Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Muckle-Wells Syndrome Market Share By Family of Cryopyrin (2016-2027)
Figure 21. North America Muckle-Wells Syndrome Market Share by End Users (2016-2027)
Figure 22. North America Muckle-Wells Syndrome Market Share by Country (2016-2027)
Figure 23. United States Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Muckle-Wells Syndrome Market Share By Family of Cryopyrin (2016-2027)
Figure 27. Europe Muckle-Wells Syndrome Market Share by End Users (2016-2027)
Figure 28. Europe Muckle-Wells Syndrome Market Share by Country (2016-2027)
Figure 29. Germany Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Muckle-Wells Syndrome Market Share By Family of Cryopyrin (2016-2027)
Figure 37. Asia-Pacific Muckle-Wells Syndrome Market Share by End Users (2016-2027)
Figure 38. Asia-Pacific Muckle-Wells Syndrome Market Share by Region (2016-2027)
Figure 39. China Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Muckle-Wells Syndrome Market Share By Family of Cryopyrin (2016-2027)
Figure 47. Latin America Muckle-Wells Syndrome Market Share by End Users (2016-2027)
Figure 48. Latin America Muckle-Wells Syndrome Market Share by Country (2016-2027)
Figure 49. Mexico Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Muckle-Wells Syndrome Market Share By Family of Cryopyrin (2016-2027)
Figure 53. Middle East & Africa Muckle-Wells Syndrome Market Share by End Users (2016-2027)
Figure 54. Middle East & Africa Muckle-Wells Syndrome Market Share by Country (2016-2027)
Figure 55. Turkey Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Muckle-Wells Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Novartis AG Revenue Growth Rate in Muckle-Wells Syndrome Business (2016-2021)
Figure 59. Istituto Giannina Gaslini Revenue Growth Rate in Muckle-Wells Syndrome Business (2016-2021)
Figure 60. Regeneron Pharmaceuticals, Inc. Revenue Growth Rate in Muckle-Wells Syndrome Business (2016-2021)
Figure 61. Charite-Universitatsmedizin Berlin Revenue Growth Rate in Muckle-Wells Syndrome Business (2016-2021)
Figure 62. Fresenius Medical Care Revenue Growth Rate in Muckle-Wells Syndrome Business (2016-2021)
Figure 63. Huaren Pharmaceutical Revenue Growth Rate in Muckle-Wells Syndrome Business (2016-2021)
Figure 64. NephroPlus Revenue Growth Rate in Muckle-Wells Syndrome Business (2016-2021)
Figure 65. Nipro Revenue Growth Rate in Muckle-Wells Syndrome Business (2016-2021)
Figure 66. Swedish Orphan Biovitrum AB Revenue Growth Rate in Muckle-Wells Syndrome Business (2016-2021)
Figure 67. Kiniksa Pharmaceuticals Revenue Growth Rate in Muckle-Wells Syndrome Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の周期的発熱症候群市場規模・現状・予測（2021年-2027年）

Global Periodic Fever Syndrome Market Size, Status and Forecast 2021-2027
QYR2104Z4515 2021年4月 99Pages
QYResearch社発行の本調査資料では、周期的発熱症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（高IgD症候群、家族性地中海熱症候群、TNF受容体関連周期症候群、クリオピリン関連周期症候群、その他）、用途別市場規模（病院、ドラッグス...

世界のゾリンジャー-エリソン症候群検査市場規模・現状・予測（2021年-2027年）

Global Zollinger - Ellison Syndrome Testing Market Size, Status and Forecast 2021-2027
QYR2104Z6110 2021年4月 92Pages
QYResearch社発行の本調査資料では、ゾリンジャー-エリソン症候群検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（合成豚セクレチン、合成人間セクレチン）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界のドラベ症候群治療市場規模・現状・予測（2021年-2027年）

Global Dravet Syndrome Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1961 2021年4月 92Pages
QYResearch社発行の本調査資料では、ドラベ症候群治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））、用途別市場規模（病院薬局、小売薬局、Eコマース、その他）、主要...

世界の腫瘍崩壊症候群市場規模・現状・予測（2021年-2027年）

Global Tumor Lysis Syndrome Market Size, Status and Forecast 2021-2027
QYR2104Z5758 2021年4月 92Pages
QYResearch社発行の本調査資料では、腫瘍崩壊症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アロプリノール、フェブキソスタット、ラスブリカーゼ、その他）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメ...

世界のチャーグストラウス症候群市場規模・現状・予測（2021年-2027年）

Global Churg Strauss Syndrome Market Size, Status and Forecast 2021-2027
QYR2104Z1332 2021年4月 99Pages
QYResearch社発行の本調査資料では、チャーグストラウス症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、免疫グロブリン、ワクチン、ステロイド、その他）、用途別市場規模（研究所、病院、クリニック、その他）、主要地域別市場規模...

世界の脆弱X症候群遺伝子検査市場規模・現状・予測（2021年-2027年）

Global Fragile X Syndrome Genetic Testing Market Size, Status and Forecast 2021-2027
QYR2104Z2456 2021年4月 97Pages
QYResearch社発行の本調査資料では、脆弱X症候群遺伝子検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、症状前検査）、用途別市場規模（病院、クリニック、診断センター）、...

世界の吸収不良症候群市場規模・現状・予測（2021年-2027年）

Global Malabsorption Syndrome Market Size, Status and Forecast 2021-2027
QYR2104Z3532 2021年4月 90Pages
QYResearch社発行の本調査資料では、吸収不良症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（栄養補助食品、プロテアーゼ・リパーゼサプリメント、抗生物質、止瀉薬、抗炎症薬、その他）、用途別市場規模（製薬会社、病院、栄養クリニック、学...

世界のバーター症候群治療薬市場規模・現状・予測（2021年-2027年）

Global Bartter Syndrome Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z0704 2021年4月 93Pages
QYResearch社発行の本調査資料では、バーター症候群治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（NSAID（非ステロイド性抗炎症薬）、RAAS阻害剤、アルドステロン拮抗薬、アンジオテンシンII受容体拮抗薬、アンジオテンシン変換酵...

世界のバーター症候群治療市場規模・現状・予測（2021年-2027年）

Global Bartter Syndrome Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0705 2021年4月 93Pages
QYResearch社発行の本調査資料では、バーター症候群治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（NSAID（非ステロイド性抗炎症薬）、RAAS阻害剤、アルドステロン拮抗薬、アンジオテンシンII受容体拮抗薬、アンジオテンシン変換酵素...

世界のセロトニン症候群市場規模・現状・予測（2021年-2027年）

Global Serotonin Syndrome Market Size, Status and Forecast 2021-2027
QYR2104Z5197 2021年4月 95Pages
QYResearch社発行の本調査資料では、セロトニン症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（セロトニン拮抗薬、支持療法、胃腸除染、その他）、用途別市場規模（病院用、診療所用、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の周期的発熱症候群市場規模・現状・予測（2021年-2027年） Periodic fever syndrome are a set of disorders characterized by recurrent episodes of systemic and organ-specific inflammation. The syndromes are diverse, but tend to cause episodes of fever, joint pains, skin rashes, abdominal pains and may lead to chronic complications such as amyloidosis. Market …
世界の脆弱X症候群遺伝子検査市場規模・現状・予測（2021年-2027年） Fragile X Syndrome Gene Test, designed to detect the Fragile X Syndrome gene Market Analysis and Insights: Global Fragile X Syndrome Genetic Testing Market The global Fragile X Syndrome Genetic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR o…
世界の観測井市場 2021：企業別、地域別、種類・用途別 The Inspection Wells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
世界のゾリンジャー-エリソン症候群検査市場規模・現状・予測（2021年-2027年） Zollinger-Ellison syndrome is a rare condition in which one or more tumors form in your pancreas or the upper part of your small intestine (duodenum). Market Analysis and Insights: Global Zollinger - Ellison Syndrome Testing Market The global Zollinger - Ellison Syndrome Testing market size is proj…
世界のチャーグストラウス症候群市場規模・現状・予測（2021年-2027年） Churg Strauss syndrome is a disorder that causes inflammation in blood vessels. This restricts the blood flow to vital organs and tissues. Sometimes it leads to permanent damage of tissues. This condition is also known as eosinophilic granulomatosis with polyangiitis. Asthma is the most common sign …